Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Core EBITDA Growth

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

AUROBINDO PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 12.5759.64-14.83-17.6213.02

What is the latest Core EBITDA Growth ratio of AUROBINDO PHARMA ?

The latest Core EBITDA Growth ratio of AUROBINDO PHARMA is 12.57 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202512.57
Mar202459.64
Mar2023-14.83
Mar2022-17.62
Mar202113.02

How is Core EBITDA Growth of AUROBINDO PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 12.57
-78.92
Mar2024 59.64
Positive
Mar2023 -14.83
Negative
Mar2022 -17.62
Negative
Mar2021 13.02 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Core EBITDA Growth ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹69,182.0 Cr 1.4% -3.6% 3.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1.4%

-3.6%

3.5%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses